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Abstract
Background: The aim was to investigate whether resident chondrocytes in human articular cartilage and in subculture
express vitamin D receptor (VDR) and the enzyme that hydroxylates the prohormone 25(OH)D3 to the active hormone
1α,25(OH)2D3, namely 1α-hydroxylase (CYP27B1). Any putative effects of vitamin D on chondrocytes were also explored.
Methods: Cartilage from human osteoarthritic knee joints, cultured chondrocytes and cells grown in 3D spheroids were
examined for the expression of VDR and 1α-hydroxylase by PCR, Western blots and immunolabelling. Receptor engagement
was judged by visualizing nuclear translocation. The effects of 25(OH)D3 and 1α,25(OH)2D3 on chondrocyte functions were
assessed in proliferation-, chondrogenesis- and cartilage signature-gene expression assays. The capability of chondrocytes to
hydroxylate 25(OH)D3 was determined by measuring the concentration of metabolites. Finally, a putative regulation of
receptor and enzyme expression by 1α,25(OH)2D3 or interleukin (IL)-1β, was investigated by Western blot.
Results: Gene expression was positive for VDR in freshly isolated cells from native cartilage, cells subcultured in monolayers
and in spheroids, whereas protein expression, otherwise judged low, was apparent in monolayers. Nuclear translocation of
VDR occurred upon 1α,25(OH)2D3 treatment. Transcripts for 1α-hydroxylase were detected in freshly isolated cells, cultured
cells and spheroids. Western blots and immunolabelling detected 1α-hydroxylase protein in all materials, while staining of
tissue appeared confined to cells at the superficial layer. A dose-dependent 1α,25(OH)2D3 production was measured when
the enzyme substrate was supplied to cell cultures. Western blots revealed that the VDR, but not 1α-hydroxylase, was
induced by IL-1β treatment in adherent cells. Proliferation in monolayers was enhanced by both 25(OH)D3 and 1α,25(OH)
2D3, and both compounds had negative effects on chondrogenesis and cartilage-matrix genes.
Conclusions: VDR expression in resident cartilage chondrocytes, generally considered differentiated cells, is elusive. A
similar pattern applies for redifferentiated chondrocytes in spheroid cultures, whereas dedifferentiated cells, established in
monolayers, stably express VDR. Both 25(OH)D3 and 1α,25(OH)2D3 are able to potentiate cell proliferation but have a
negative impact in proteoglycan synthesis. Chondrocytes express 1α-hydroxylase and may contribute to the
production of 1α,25(OH)2D3 into the joint environment. Effects of vitamin D could be unfavourable in the
context of cartilage matrix synthesis.
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Background
Osteoarthritis (OA) is a debilitating degenerative disease
of the joint affecting middle-aged and older people and
the pathogenesis is considered multifactorial [1]. Over the
last decades, mounting evidence suggests that OA develops
as a cause of inflammation in addition to the mechanical
aspects [2]. Vitamin D is a predecessor of the secosteroid
hormone 1α,25(OH)2D, which plays a pivotal role for
appropriately regulated calcium required for a normal bone
turnover. Of importance, 1α,25(OH)2D has been suggested
to dampen inflammation-driven diseases such as rheuma-
toid- and osteoarthritis [3]. Exogenous sources of vitamin
D3 are mainly fatty fish and fortified food items, whereas
the predominant source is the endogenous production
from cholesterol in sun-exposed skin. After hydroxylation
in the liver, the vitamin circulates as the prohormone
25(OH)D3 bound to D-binding protein (90%) and albumin
(10%). Likewise, the active hormone 1α,25(OH)2D3 is trans-
ported by these proteins, but circulates in a concentra-
tion < 0.1% of that of the prohormone. Less than 1% of
both metabolites are unbound by carrier proteins. The
hydroxylation of 25(OH)D3 to 1α,25(OH)2D3 is facilitated
by the enzyme 1α-hydroxylase, which is primarily located
in the kidneys. However, there is compelling evidence of an
extra-renal distribution of the enzyme, including local
induction by the immune system [4]. The effect of vitamin
D in the extra-renal compartments are considered auto- or
paracrine, and represent an entirely new paradigm of vita-
min D actions compared to the endocrine action of renal
vitamin D [5]. The active hormone binds the vitamin D
receptor (VDR), which is abundantly expressed in the
intestine, kidneys, parathyroid and bone; while it is
expressed in costal cartilage, its presence in articular cartil-
age is less settled [6].
Several studies have suggested a link between vitamin D
status and OA; some have found that individuals deficient
in vitamin D have an increased risk of progressive knee-
osteoarthritis, and there are reports of a pain reducing
effect of oral supplementation [7, 8]. Both 25(OH)D3 and
1α,25(OH)2D3 have been detected in synovial fluid [4, 9].
The presence of the receptor in human articular cartilage
and chondrocytes has been previously investigated with
divergent outcomes [10, 11], and the biological effect of vita-
min D on cartilage pathophysiology remains uncertain. In
rat chondrosarcoma cells, 1α,25(OH)2D3 dose-dependently
induced MMP13, a matrix metalloprotease which degrades
the extracelluar matrix [12]. 1α,25(OH)2D3 has also been as-
sociated with hypertrophy and mineralization of OA chon-
drocytes [13].
The aim of this study was to investigate whether the
previously described expression patterns of VDR in hu-
man articular cartilage and subcultured cells could be
confirmed by PCR, Western blots and immunolabelling.
It was also questioned whether receptor activation occurred
upon ligand binding, and whether this could be recorded
by biological readouts such as promoted chondrogenesis,
cell proliferation or cartilage signature gene expression.
Furthermore, in view of the previously reported presence
of 1α,25(OH)2D3 in synovial fluid, it was addressed
whether the sole source was the circulation or if the hor-
mone could also be attributed to a local production by
chondrocytes expressing 1α-hydroxylase. Previous experi-
ments are described using cartilage tissues and chondro-
cytes expanded in adherent monolayer cultures. Since
chondrocytes are known to dedifferentiate upon mono-
layer expansion, thus undermining the extrapolation of
findings to cartilage conditions, we included assays utiliz-
ing freshly isolated chondrocytes in a differentiated stage,
and 3D culture assays where the chondrocyte redifferenti-
ate to a chondrocyte-like phenotype [14].
Methods
Human material
Cartilage tissues were collected from macroscopically
healthy looking areas of cartilage on the lateral femoral
condyle of patients with osteoarthritis undergoing total
knee replacement procedures (N = 13, age: 40–78). Pa-
tient records were searched to exclude any patients with
rheumatic disease, while both secondary posttraumatic
and primary osteoarthritis patients were included. The
material was collected with the patient’s written consent
and all samples were anonymized at time of collection.
All methods were performed in accordance with the
relevant guidelines and regulations, and the study was
approved by the regional ethics committee (2015/1730/
REK Nord).
Chondrocytes isolation and culturing
Suspension cultures
Cartilage biopsies, in which bone was meticulously
excluded, were minced into ~1mm3 pieces and enzymati-
cally digested in Collagen type XI (Cat. no. C9407, Sigma
Aldrich) for 4–6 h until 95% degraded. Cells were counted
using a haemocytometer, and suspension cultures were
established in 24-well ultra-low binding plates (Cat. no.
3473, Corning, VWR) at 4 × 105 cells/well in DMEM (Cat.
no. D5796, SigmaAldrich) supplemented with 62 mg/L as-
corbic acid (Cat. no. 103033E, BDH Laboratories), 1%
penicillin/streptomycin (P/S, Cat. no. P0781, Sigma-
Aldrich) and 1% Fetal Bovine Serum (FBS, Cat. no. S0615,
Biochrom). Suspension cultures were allowed to equili-
brate for 24 h in at 37 °C and 5% O2 before being treated
with IL-1β (Cat. no. 200-01B, Peprotech) at 10 ng/mL,
1α,25(OH)2D2 (Cat. no. 11174, Cayman Chemical) or
1α,25(OH)2D3 (Cat. no. 71820, Cayman Chemical) at 10
−8 M for 24 h.
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Monolayer cultures
Immediately after tissue digestion, chondrocytes were
seeded in polystyrene T25 flasks and serially expanded in
monolayer cultures in DMEM supplemented with
ascorbic acid, P/S and 10–20% FBS until confluence in
T175 cultures flasks. Monolayer cells were used for
experimentation at passages 2–5. Pieces of bone removed
from cartilage biopsies were minced and explant cultured
in DMEM supplemented with 20% FBS for 2 weeks to
obtain the osteoblasts used as controls in Western blots.
3D cultures
Scaffold-free multicellular spheroid cultures of chondro-
cytes were established from chondrocytes expanded in the
presence of vehicle, 25(OH)D3 or 1α,25(OH)2D3 at 10
−7 M
until confluency. The cells were detached from the culture
flasks using an enzyme-free dissociation solution (Cat. no.
S-014-B, Merck Millipore) and transient trypsinization
(Trypsin-EDTA, T4049, Sigma-Aldrich) before plating in
round bottom ultra-low attachment 96-well plates (Cat. no.
7007, Costar) at a density of 5 × 104 in 150 μL DMEM
supplemented with 10 ng/mL TGF-β3 (Cat. no. 100-21C,
Peprotech), 10 ng/mL BMP-2, 1:1000 Insulin-Transferrin-
Selenium (ITS, Cat. no. 354351, BD Biosciences). The
augmentation with vehicle, 25(OH)D3 or 1α,25(OH)2D3 at
10−7 M was continued through 3D culturing for 2 weeks
for spheroids used to evaluate chondrogenesis. Spheroids
used for immunolabelling of VDR and 1α-hydroxylase
were propagated for 2 days or 3 weeks in chondro-
genic medium alone.
Histology and immunohictochemistry
Cartilage biopsies, two-day spheroids and three-week
spheroids were fixed in 4% formalin overnight. Spheroids
were embedded in 1% agarose before, along with the car-
tilage biopsies, they were cast and cut into 4 μm sections.
Slides were rehydrated and antigen retrieval was achieved
by placing the slides in a 60 °C citrate buffer for 60 min.
The SuperPicture kit (Cat. no. 879673, Novex,
LifeTechnologies) was used, along with specific antibodies
targeting 1α-hydroxylase (Cat. no. ABIN2118284,
Antibodies-online.com) and VDR (Cat. no. Sc-13,133,
Santa Cruz) [15]. As previously described [16], slides from
two-day and three-week controls and vitamin D-treated
spheroids were prepared and stained with Alcian blue to
detect glycosaminoglycan production. Pictures were
developed using the Zeiss Axiophot photomicroscope
(Carl Zeiss, Oberkochen, Germany), and the images were
evaluated by three investigators using the Bern score to
assess chondrogenicity [17].
Immunofluorescence
Chondrocytes were cultured until confluency seeded on
2-well chamber slides (Cat. no. 177429; NUNC Lab
Tek), and incubated for 24 h before being treated with
vehicle or 1α,25(OH)2D3 at 10
−8 M for 2 h, and subse-
quently subjected to fixation. Concomitant fixation-
permeabilization of cells was done using 100% ice-cold
methanol for 8 min, followed by serial washings with
PBS for the rehydration of cells. For protein detection,
fixed cells were incubated with primary antibodies
against 1α-hydroxylase and VDR. Alexa 546-conjugated
secondary antibodies targeting rabbit (Cat. no. A11010,
Life Technologies) or mouse IgG (Cat. no. A11003, Life
Technologies), respectively, were used to visualize 1α-
hydroxylase and VDR in an appropriate microscope.
Western blot
Protein was extracted from freshly isolated chondrocytes,
suspension cultures and monolayer- expanded cultures
using the NP-40 buffer (150 nM NaCl, 50 mM Tris-HCl,
1% Igepal), supplemented with protease inhibitor
(Complete, EDTA-free, Cat. no. 11873580001, Roche).
Protein concentration was measured using a colorimetric
assay (Cat. no. 500-0116, BioRad), and separated along
with BLUeye Prestained Protein Ladder (Cat. no. PM007-
0500, Sigma-Aldrich) and MagicMark™ XP Western
Protein Standard Ladder (Cat. no. LC5602, Novex, Life
Technologies) using TruPage gels (Cat. no. PCG2003,
Sigma-Aldrich). The protein input was 40 μg/lane for
cartilage samples, 45 μg/lane for suspension cultures and
20 μg/lane for cultured cell samples. Proteins were
transferred to PVDF membranes, incubated for 1 h in a
dry milk buffer and incubated overnight at 4 °C with 1α-
hydroxylase (1:200 in BSA buffer) or VDR antibody (1:100
in dry milk buffer). Next, the membranes were incubated
with secondary α-rabbit antibody (Cat. no. sc-2004, Santa-
Cruz) and α-mouse antibody (Cat. no. sc-2005, Santa-
Cruz) for 1 h at room temperature, and lastly, a
chemiluminescence detection solution (Cat. no. 170-5040,
BioRad) was applied before images were procured using
an ImageQuant LAS 4000 CCD camera. Beta-actin anti-
body (Cat. no. SAB5500001, Sigma-Aldrich) was used as a
loading control, relative density was assessed using Image
Studio Lite 5.2 and a Dunnett’s test used to compare the
treated groups to the control group.
PCR
Suspension cultured cells and three-weeks spheroid
cultures were harvested, and RNA was extracted using
the RNeasy Micro Kit (Cat. no. 74004, Qiagen). Lysates
were dissolved in TissueLyser (Qiagen), homogenized
using QiaShredder columns (Cat. no. 79654, Qiagen),
and cleaned and eluted according to the manufacturer’s
instructions. RNA from monolayer expanded chondro-
cytes was extracted using the PerfectPure Cultured Cell Kit
(Cat. no. 2900319, 5prime) according to the manufacturer’s
protocol. RNA concentration was measured by Nano-Drop
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2000 and 35 ng of each sample was reverse-transcribed to
cDNA using qScript (Cat. no. 95047, Quanta Biosciences,
VWR). The PCR reaction included JumpStart REDTaq
ReadyMix, cDNA and specific primers targeting 1α-
hydroxylase (CYP27B1) and VDR (Table 1), and was ampli-
fied for 35 cycles using an MJ Research thermal cycler.
Products were separated in FlashGels (Cat. no. 57023,
Lonza, Fisher Scientific), and images were obtained using
an ImageQuant LAS4000 camera system.
qPCR
RNA was extracted from monolayer cultures propagated in
6-well plates and treated with vehicle, 25(OH)D3 or
1α,25(OH)2D3 at 10
−6 M and 10−7 M for 72 h. Extracts
were used in a qPCR assay where each reaction contained
5 μL Precision Fast ROX MasterMix (Primer Design),
0.5 μL hydrolysis probe (Invitrogen), 2.5 μL H2O and 2 μL
cDNA. Hydrolysis probes (Life Technologies by Fisher Sci-
entific) include: collagen type I alpha 1 chain (COL1A1,
Assay ID: Hs00164004_m1), collagen type II alpha 1 chain
(COL2A1, Hs00264051_m1), aggrecan (ACAN,
Hs00153936_m1), versican (VCAN, Hs00171642_m1),
SRY-box 9 (SOX9, Hs00165814_m1), cytochrome P450
family 24 subfamily A member 1 (CYP24A1,
Hs00167999_m1), vitamin D receptor (VDR,
Hs01045843_m1) and ribosomal protein L13a (RPL13A,
Hs04194366_g1, reference gene). Reactions were run in
BrightWhite 96-well plates (PrimerDesign) using a StepO-
nePlus™ Real-Time PCR System. The dCq was calculated
by subtracting the reference gene from the gene of interest
so that a higher dCq value represents an upregulation
and vice versa. A Dunnett’s test was used to compare
treated samples to the control samples.
25(OH)D3 hydroxylation assay
To detect the hydroxylation of 25(OH)D3 to
1α,25(OH)2D3, parallel 6-well plates with and without
confluent chondrocytes were challenged with 25(OH)D3 at
0, 50, 250 and 500 nM for 24 h. Supernatants were
collected, and 1α,25(OH)2D3 was measured using an auto-
mated immunometric assay (Diasorin) at the Hormone
Laboratory, Oslo University Hospital, Norway. Conversion
attributed to 1α-hydroxylase activity was calculated as the
difference between 1α,25(OH)2D3 in wells with and without
cells in order to cancel out any spontaneous conversion. A
linear model was used to evaluate the correlation between
25(OH)D3 and 1α,25(OH)2D3.
Proliferation assay
Chondrocytes from two donors were plated in E-plate
VIEW 16 (Cat. no. 06324746001, ACEA Biosciences) at
3000 cells per well in 100 μL DMEM, supplemented
with 10% FBS and vehicle, 25(OH)D3 or1α,25(OH)2D3 at
10-6 M for 80 h and real-time proliferation was moni-
tored using the xCELLigence RTCA system (Roche
Diagnostics). The cell-index was normalized to 25 h (1 h
after treatment) and log 2 converted to more accurately
display growth rate [18].
Immunoelectron microscopy
Chondrocytes cultures from two different donors estab-
lished in 10 cm Ø dishes were fixed in 8% formaldehyde in
a 200 mM HEPES buffer, pH 7.5, for 24 h, collected by gen-
tly scraping of cells and centrifuged in an Eppendorf micro-
fuge. After infusion for 30 min with 2.3 mol/L sucrose
containing 20% polyvinylpyrrolidone, pellets were mounted
on a specimen holder and frozen in liquid nitrogen.
Cryosections were prepared, and immunolabeling was
performed as described elsewhere [19]. Antibodies against
VDR and 1α-hydroxylase (diluted 1:25) were detected by
protein A-gold complexes, and the dried sections were then
examined in a JEOL JEM 1010 transmission electron
microscope (JEOL, Tokyo, Japan) operating at 80 kV.
Moreover, negative controls were routinely included in
parallel by the omission of primary antibodies.
Statistics
Data analysis and figures were acquired using RStudio [20],
with tidy, plyr, dplyr, broom, data.table, purrr, ggplot2 and
ggthemes packages [21–28]. Differences were considered
significant at p < 0.05.
Results
Chondrocyte dedifferentiation and redifferentiation
In this study, we have investigated the expression of vita-
min D receptor and 1a-hydroxylase on human articular
chondrocytes established in different experimental con-
ditions comprising native tissue, suspension cultures, ad-
herent cells/monolayer cultures and 3D spheroids
cultures. This approach is relevant if we take into con-
sideration that chondrocytes change their phenotype
during cell expansion in vitro (dedifferentiation) and that
they are able to gain (at least in part) their phenotypic
traits in 3D cultures (redifferentiation) [14]. A qPCR
assay was performed, comparing gene expression of car-
tilage signature genes between suspension cultures and
monolayer cultures, and the results indicate that the sus-
pension cultures were indeed in a differentiated stage
Table 1 PCR Primers
VDR F 5′-ACC AAG CTC ACA GTT CCT CG-3′
VDR R 5′-CGG CAG GGA GAT CAT GAC TC-3′
CYP27B1 F 5′-ACC ATG GTC TCT CTG CTT GC-3′
CYP27B1 R 5′-GCC CAA AGA TGT CTC TGC CT-3′
APRT F 5′-CCCGAGGCTTCCTCTTTG GC-3′
APRT R 5′-CTCCCTGCCCTTAAGCGAGG-3′
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compared to the dedifferentiated monolayers (Add-
itional file 1: Figure S1).
Expression of 1α-hydroxylase in cartilage tissue and cells
By using conventional PCR, 1α-hydroxylase mRNA was
detected in freshly isolated cells from native cartilage,
chondrocytes in monolayers and in 3D spheroids culti-
vated for 3 weeks in chondrogenic conditions (Fig. 1f ).
By immunolabelling of native cartilage, 1α-hydroxylase
appears confined to chondrocytes residing in the superfi-
cial layer (in Fig. 1a and b). Chondrocytes in monolayers
and in spheroids were also positively stained (Fig. 1c and
d). In Western blots, an expected 58 kD band in protein
extracts from native cartilage, suspension and monolayer
cells as well as in a positive control, i.e. osteoblast cul-
ture, was confirmed (Fig. 1e). In subcellular distribution
experiments, utilizing immunoelectron microscopy, 1α-
hydroxylase was found in the cytoplasm and in electron-
dense mitochondria-like structures (Fig. 3b).
Expression of VDR in cartilage tissue and cells
Results show that mRNA transcripts encoding VDR was
detected in all samples, i.e. in freshly isolated chondro-
cytes, monolayer cultured cells and three-weeks spher-
oids (Fig. 2f ). As judged by immunolabelling, no staining
of the VDR protein was identified in cartilage (Fig. 2a) in
contrast to the staining observed in intestinal mucosa
used as a positive control (Fig. 2b). In monolayer ex-
panded cells, staining was apparent in the cytoplasm and
the nucleus (Fig. 2c). In 3D spheroid cultures, immuno-
staining was negative already 2 days after 3D culture ini-
tiation (Fig. 2d). Western blotting confirmed these
findings by the occurrence of an expected 53 kD band in
extracts from monolayer cells and the positive control,
primary osteoblasts culture (Fig. 2e). Of note, the nearly
invisible band corresponding to the loading control
beta-actin in cartilage samples underscores the low
levels of cell-associated proteins compared to extracellu-
lar matrix (ECM) proteins in such samples. At the sub-
cellular level, VDR was found primarily in cytoplasmic
regions and sporadically in the nucleus (Fig. 3a).
Receptor and enzyme are functional
VDR engagement was investigated by immunolabel-
ling of nuclear translocation of the receptor upon
ligand binding. In Fig. 4c and d, the predominant-
nuclear staining of VDR after 2 h of treatment with
1α,25(OH)2D3 can be observed, compared to the
mixed cytoplasmic-nuclear staining of VDR from un-
treated cells (Fig. 4a and b).
Evidence for 1α-hydroxylase activity was arranged by
supplementing cultured cells with its substrate 25(OH)D3
followed by the assessment of 1α,25(OH)2D3 concentration
after 24 h. It was revealed that 1α,25(OH)2D3 was dose-
dependently produced in cell supernatants (Fig. 4e).
Induced expression of VDR, but not 1α-hydroxylase
by IL-1β
Aiming at exploring potential receptor and/or enzyme
regulation during inflammatory conditions, VDR and 1α-
hydroxylase expression was judged by Western blotting in
freshly isolated cells and in monolayers after treatment
with the pro-inflammatory cytokine IL-1β or the active
hormone 1α,25(OH)2D3. Bands occurring after blotting
from three randomly chosen donors were subjected to
densitometric assessment. In suspension culture prepara-
tions, an increased expression of 1α-hydroxylase
(CYP27B1) was detected in two out of three samples, but
the lack of regulation in one donor made the total effect
not significant. In contrast, the expression of VDR was
uniform across treated and untreated samples (Fig. 5a). In
monolayer samples, the VDR expression was amplified al-
most three-fold after IL-1β stimulation, an alteration that
was judged as statistically significant (Fig. 5b), while the
expression of 1α-hydroxylase was unaltered by IL-1β or
1α,25(OH)2D3.
Both 25(OH)D3 and 1α,25(OH)2D3 influence chondrogenesis
and expression of cartilage signature genes
Last, the potential effects of 25(OH)D3 and
1α,25(OH)2D3 on major chondrocyte functions was
investigated. Since the expression of the VDR receptor
was more evident in monolayer cells, and scarcely detect-
able in freshly isolated or 3D conditions, we resorted to
chondrocytes in monolayers to study vitamin D effects.
For chondrogenesis, cells established in monolayers were
incubated in the presence or absence of 25(OH)D3 or
1α,25(OH)2D3 for 1 week prior to 3D spheroids formation
and incubation for 2 weeks in a chondrogenic environ-
ment supplemented with 25(OH)D3, 1α,25(OH)2D3 or
vehicle. The resulting 3D structures were stained with the
glycosaminoglycan marker Alcian blue (Fig. 6a-c). A semi-
quantitative visual scoring of Alcian blue-stained spher-
oids from three different donors (Bern score) indicated a
detrimental effect of both 25(OH)D3 and 1α,25(OH)2D3
on proteoglycan synthesis and chondrogenesis (Fig. 6d).
Effects of 25(OH)D3 or 1α,25(OH)2D3 on cartilage-
signature gene expression were studied by qPCR (Fig.
6f ). Regulation of CYP24A1 expression was used as an
internal positive control for 1α,25(OH)2D3 action. Cul-
tures treated with 25(OH)D3 or 1α,25(OH)2D3 both ex-
hibit a significant increase in expression of CYP24A1
compared to the untreated cultures, while the VDR tran-
script remained unaffected. Both 25(OH)D3 and
1α,25(OH)2D3 significantly increased the expression of
VCAN, whereas the expression of ACAN (the cartilage
proteoglycan) was significantly reduced compared to the
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control. The expression of Collagen type I (COL1A1)
and SOX9 were not affected by 25(OH)D3 nor
1α,25(OH)2D3 treatment. Expression of Collagen type
II remained undetectable in both treated and
untreated samples.
On the other hand, we found that both 25(OH)D3
and 1α,25(OH)2D3 had a positive impact on cell pro-
liferation, both inducing a slight increase in the
growth rate compared to vehicle (Fig. 6e). The three
donors included in the study exhibited different growth
rates, obscuring any significant differences.
Discussion
Osteoarthritis (OA) is a disease of the entire joint af-
fecting cartilage, subchondral bone, the synovial mem-
brane and ligaments. Clinically, the disease is
characterized by joint space narrowing, osteophyte
formation and sclerosis. At a microscopic level, OA is
characterized by a loss of extracellular matrix, chon-
drocyte hypertrophy, cell proliferation and calcifica-
tion [29]. The role of Vitamin D in the OA context
remains controversial. Synoviocytes secrete inflamma-
tory mediators into the synovial fluid, and it appears
Fig. 1 Cartilage at 100 × (a) and 400 × (b) magnification, arrows indicate chondrocytes labelled with 1α-hydroxylase antibody and corresponding
green labelling of cultured chondrocytes (c). In the two-week spheroids (d, 100×) brown staining of chondrocytes indicate the presence of 1α-
hydroxylase. Western blot (e) of cartilage, monolayer chondrocytes and osteoblasts labelled with 1α-hydroxylase antibody (58 kD) and β-actin (45
kD, loading control). PCR (f) of cartilage, monolayer chondrocyte and spheroids (3D) using primers targeting 1α-hydroxylase (521 bp) and APRT
(300 bp, quality control). Images represent the outcome of investigation of cells and tissues from three different donors
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that elevated levels of 1α,25(OH)2D3 may increase the
OPG/RANKL ratio, along with a reduced IL-6
production that together contributes to a dampened
inflammation [30]. In contrast, it was reported that in
human articular chondrocytes, 1α,25(OH)2D3 induced
MMPs and calcification that are usually considered
detrimental events [11, 13]. The picture becomes
more entangled after considering the studies that have
investigated VDR expression in human cartilage. An
early study from the 80’s claimed that VDR is absent
in resident cartilage cells, but acquires VDR during ex-vivo
cultivation, i.e. cells considered as dedifferentiated [10]. A
more recent report argues that VDR is inconsistently
expressed in healthy human cartilage (donor dependent),
but enhanced in OA cartilage [11]. Because of the existing
dubiety, we pursued studying VDR expression in cartilage
tissue and cells by different means. Preceded by the meas-
urement of 25(OH)D3 in synovial fluid from patients with
rheumatoid arthritis (mean 11,0 nM, results not shown), it
was importunate to question whether the congeneric
1α,25(OH)2D3 hormone could be produced locally in the
joint by chondrocytes. This would require the recognition
that chondrocytes express 1α-hydroxylase.
In line with previous publications [10, 31], VDR tran-
scripts were detected in cartilage tissue and monolayers,
while in our hands detecting VDR protein in native
Fig. 2 Cartilage (a, 400×), normal colon (b, 400×), cultured chondrocytes (c) and two-day spheroids (d, 100×) labelled with a VDR antibody. In
normal colon the brown staining of the cytoplasm represent VDR labelling and in cultured chondrocytes the VDR is correspondingly visualised by
red staining, while in cartilage and two-week spheroids there is no labelling of VDR. Western blot (e) of cartilage, monolayer chondrocytes and os-
teoblasts labelled with VDR antibody (53 kD) and β-actin (45 kD). PCR (f) of cartilage, monolayer chondrocytes and spheroids (3D) using primers
targeting VDR (336 bp) and APRT (300 bp). Images represent the outcome of investigation of cells and tissues from three different donors
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cartilage by immunohistochemistry and Western blot
was less evident. The expected VDR band is hardly
recognizable in Fig. 2e (cartilage D1, the D2 and D3 are
judged negative). Of note, the β-actin protein band from
cartilage samples was also weak even though equal
amount of proteins were loaded in wells. This may reflect
a very low concentration of cell associated proteins com-
pared to ECM proteins in samples prepared by short en-
zymatic digestion. In Fig. 5a, corresponding to the
Western blot of suspension cells phenotypically similar to
native cells and devoid of matrix proteins, it is more evi-
dent that the VDR protein is present in the samples. No
previous publication could be recovered for a comparison
on the Western blot subject, and our judgment is that
VDR is expressed by resident cells in cartilage, although at
very low levels.
Through immunolabelling it has previously been dem-
onstrated that chondrocytes express the VDR protein in
OA cartilage and monolayer cells [11]. The latter was
confirmed here (Fig. 2c), though no signal was recorded
by histological immunolabelling (Fig. 2a). It has been
claimed that many VDR antibodies not only bind VDR,
but also possess non-specific interactions with other
unidentified proteins, determined by both immunoblot-
ting and histochemistry [15]. These authors recom-
mended using the antibody applied in the present study
for both purposes. The questioned utility of different
antibodies could explain the current divergent findings.
All in all, despite the failure to detect the VDR protein in
cartilage tissue by immunohistochemistry, the results from
protein and transcript detection in suspension cell cul-
tures represent an evidence that differentiated chondro-
cytes express VDR, which is also in agreement with both
the previous report and reports on enhanced expression
in OA cartilage and rheumatoid lesions [31]. In line with
what we observed in tissue, a negative immunolabelling of
redifferentiated cells, i.e. those in spheroids was recorded.
Although VDR transcripts were detected, no or an
insufficient amount of protein in spheroids enabled
VDR detection.
After entering the cell, 1α,25(OH)2D3 binds the VDR,
and the VDR-ligand complex translocates to the nucleus
where it triggers a tissue-specific change in gene-
transcription, resulting in altered growth, differentiation
or functional activity [32]. In adherent chondrocytes,
receptor translocation is evident in Fig. 4 a-d where the
immunostaining shifts from a mixed nuclear/cytoplas-
mic stain in untreated chondrocytes, to a predominant
nuclear staining after the addition of 1α,25(OH)2D3. This
provides evidence of the internalization of 1α,25(OH)2D3
and subsequent receptor engagement.
An objective in this study was to investigate a putative
alteration of receptor or enzyme expression during an
inflammatory condition arranged by treating cells with
cytokine or hormone. Cells in both suspension and mono-
layers were subjected to either IL-1β or 1α,25(OH)2D3
treatment, and relative amounts of VDR protein were
recorded by Western blot. In monolayer samples, the
VDR was significantly upregulated upon treatment with
IL-1β (Fig. 5b), while this effect could not be detected in a
suspension culture condition (Fig. 5a). The upregulation
detected in monolayer cultures is in agreement with previ-
ous publications reporting upregulated VDR expression
during various inflammatory conditions and could be
associated to the elevated receptor expression reported in
OA cartilage samples [31].
In osteoclasts, there has been observed an upregula-
tion of VDR transcripts upon 1α,25(OH)2D3 stimulation
at 10−7 M, but not at a 10−8 M level [33]. In the present
study, 10−8 M was used to resemble the amounts found
in the synovial fluid, yet it appeared insufficient to affect
VDR expression at the protein level (Fig. 5). This indicates
a b
c d
Fig. 3 Subcellular distribution of VDR (a) and 1α-hydroxylase (b) in chondrocytes assessed by immunoelectron microscopy. Panels c and d are
magnifications of a and b respectively. Gold particles are marked with arrowheads. N = nucleus, M = mitochondria, PM = plasma
membrane, CP = cytoplasm
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that a supplementary local hormone production is required
[34], or that osteoblasts and chondrocytes are unrelated
cells on this subject.
It is claimed that in general 1α,25(OH)2D3 has an
anabolic effect on tissues [35]. In studies of proliferation,
the mutual potency of 25(OH)D3 and 1α,25(OH)2D3 was
proven by the changes observed with each of the
compounds. A similar pattern was seen in three donors,
indicating enhanced proliferation after 25(OH)D3 or
1α,25(OH)2D3 treatment (Fig. 5e). Chondrocyte prolifer-
ation is frequently observed in OA cartilage [29],
possibly as an attempt of cells to repair the damaged
cartilage or to compensate the catabolic processes
established in the joint.
Moreover, from the spheroid model that investigates
chondrogenic potential, a corresponding effect was
observed resulting in a significant loss of matrix production
(Fig. 6 a-d) during treatment with 25(OH)D3 or
1α,25(OH)2D3, but only after applying the assay to chon-
drocytes that also were expanded in the presence of
25(OH)D3 or 1α,25(OH)2D3. Spheroids prepared from
chondrocytes propagated in standard growth medium were
indifferent to the presence of 1α,25(OH)2D3 during 3D
culture (data not shown), underpinning that chondrocytes
in 3D cultures rapidly repress VDR expression.
The gene expression profile of cultured cells exposed
to 25(OH)D3 and 1α,25(OH)2D3 indicated an unfavour-
able effect on proteoglycan transcripts ACAN and
VCAN, while the expression of VDR, COL1A1 and
SOX9 was unchanged. This outcome is in accordance
with the lower expression of proteoglycans observed by
Alcian blue staining of treated spheroids. Interestingly,
the CYP24A1, that was included as a positive control of






Fig. 4 Cultured chondrocytes labelled with VDR antibody (b and d) and merged image of DAPI and VDR labelling (a and c). Cells in a and b are
untreated, while c and d are treated with 1α,25(OH)2D3 for 2 h. Cultured chondrocytes treated with 50, 250 or 500 nM 25(OH)D3 for 24 h
compared to level of 1α,25(OH)2D3 measured in the supernatant (e), results represent the experiment on cells from one donor
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upon 25(OH)D3 treatment (Fig. 6 f), supporting the
notion that chondrocytes endogenously express 1α-
hydroxylase.
Striking and novel findings in this study were the
expression of transcripts for the enzyme 1α-hydroxylase
and the presence of the encoded protein in human osteo-
arthritic articular cartilage, in suspension cells, in mono-
layers and 3D spheroid cultures (Fig. 1). The expression in
all these conditions could indicate a constitutive expres-
sion pattern. No evidence for 1α-hydroxylase regulation
by IL-1β or 1α,25(OH)2D3 in differentiated suspension
cells or dedifferentiated monolayer cells was recorded,
which is in line with previous studies on osteoblasts [33].
Previously, the enzyme was detected in rat growth plate
chondrocytes [36], but to the best of our knowledge there
are no reports on its presence in human articular cartilage
or chondrocytes. Expression of 1α-hydroxylase in cartilage
from healthy donors remains to be determined.
The level of 25(OH)D3 and 1α,25(OH)2D3 in the
synovial fluid of inflamed joints in patients with
rheumatoid arthritis has been measured to 20 nM
and 25 pM, respectively [4]. After oral administration
of vitamin D, the level of 1α,25(OH)2D3 in synovial
fluid has been measured to up to 100 nM [37]. Based
on these measurements, and to meet the sensitivity of
the assay, chondrocytes were challenged with 50, 250
and 500 nM 25(OH)D3, resulting in a conversion to
50, 150 and 300 pM 1α,25(OH)2D3, respectively (Fig.
4e). Since cell-free controls were subtracted to ac-
count for spontaneous 1α-hydroxylation, the results
imply that the chondrocyte exhibits 1α-hydroxylase
activity that may contribute to the pool of 1α,25(OH)2D3
in synovial fluid, an action that has previously been attrib-
uted solely to macrophages in synovial fluid [4, 38].
This study has provided strong evidence for 1α-
hydroxylase being expressed in human articular chon-
drocytes, at least in OA-derived chondrocytes, whereas
evidence for a VDR expression is weaker, except in
culture-expanded cells. The activity of the 1α-hydroxylase
was supported by the conversion of 25(OH)D3 to
1α,25(OH)2D3 (Fig. 4e) and indirectly by the assays pre-
sented in Fig. 6 showing comparable outcomes from treat-
ment with 25(OH)D3 and 1α,25(OH)2D3. Hence, the co-
expression of these proteins enables auto- and paracrine
cell activity, exemplified here by impaired matrix produc-
tion, augmented cell proliferation and shifted ACAN/
VCAN expression after the application of either
1α,25(OH)2D3 or 25(OH)D3 (Fig. 6). These changes in
chondrocyte activity are indeed associated with OA pro-
gression [39], however since the functional experiments
were conducted on dedifferentiated cells, some caution is
advised in extrapolating these results to in vivo conditions.
On the other hand, as a result of the increased expression
of VDR during inflammatory conditions reported by us and
others [31], some of the actions described in Fig. 6 may be
part of the picture during OA and RA pathology.
The extent and types of effects 1α,25(OH)2D3 have
on resident cells in healthy cartilage remains to be
uncovered, yet a probable paracrine action affecting
neighbouring cells and tissues is apparent. However,
the numerous VDR responsive elements in DNA and
VDR’s capability to additionally engage several intra-
cellular signalling systems, such as protein kinase C
and phosphatidyl-inositol-3′ kinase reviewed in [40],
vouch for a plethora of biological readouts beyond the
a
b
Fig. 5 Western blots targeting VDR and 1α-hydroxylase in chondrocyte
suspension cultures (a) and monolayer cultures (b) exposed to IL-1β
(10 ng/mL) or 1α,25(OH)2D3 (10−8 M) for 24 h; controls are untreated
cells. Graphs show the corresponding protein expression by densitometry
in samples from three different donors. Error bars represent 95% CI
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scope of this study to be investigated. Thus, this study does
not rule out any anti-inflammatory effects of vitamin D on
the joint as a whole.
Conclusion
To conclude, we report here a novel finding on the vita-
min D converting enzyme, 1α-hydroxylase, in human
articular chondrocytes along with compelling evidence
of the enzyme facilitating the conversion of 25(OH)D3
to the active hormone, 1α,25(OH)2D3. The expression of
the vitamin D receptor is more elusive and reproducible
experiments are limited to monolayer conditions where
the expression of the VDR is more evident. The overall
effect of both 25(OH)D3 and 1α,25(OH)2D3 include
diminished matrix production, enhanced proliferation
and inversed expression of ACAN and VCAN, all pointing
to an unfavourable effect of vitamin D on matrix synthesis.
Additional file
Additional file 1: Figure S1. qPCR. Relative expression of cartilage
signature genes in donor matched suspension- and monolayer culture
samples from three donors. Suspension cultures samples were
challenged with vehicle, 1α,25(OH)2D2 or 1α,25(OH)2D3 at 10-8 M for 24
hours. The qPCR reaction was setup as described in material and
methods. Collagen type IX alpha 1 chain (COL9A1, Hs00932129_m1) and
collagen typeX alpha 1 chain (COL10A1, Hs00166657_m1) hydrolysis
probes (Life Technologies by Fisher Scientific) were included in addtion






Fig. 6 Alcian blue staining of spheroids maintained in control medium (a) 25(OH)D3 (b) or 1α,25(OH)2D3 at 10−7 M (c) for 2 weeks. Treated and
untreated spheroids from three different donors histologically evaluated by Bern Score (d). Proliferation (e) of monolayer chondrocytes under
continuous stimulation with 25(OH)D3, 1α,25(OH)2D3 or vehicle for 80 h in three donors. Ribbons represent 95% confidence interval and N
indicates the time of normalization. Cartilage signature gene expression in monolayer cultures from three donors (f). Error bars represent one
standard deviation, while horizontal bars and values represent p-values resulting from the comparison of means of the treated samples to the
mean of the vehicle samples
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reference gene from the gene of interest so that a higher dCq value
represents an upregulation and vice versa. Delta Cq values were mean-
centred and autoscaled, and normalized to a suspension culture control
sample to obtain ddCq [1]. A Dunnett’s test was used to compare the
treated suspension cultures samples and the untreated monolayer samples to
the suspension culture control sample. Error bars represent 95 % confidence
intervals. References 1. Willems E, Leyns L, Vandesompele J. Standardization of
real-time PCR gene expression data from independent biological replicates.
Anal Biochem. 2008;379:127–9. doi:10.1016/j.ab.2008.04.036. (EPS 912 kb)
Abbreviations
1α,25(OH)2D3: 1α,25-dihydroxy vitamin D3 – Calcitriol; 25(OH)D3: 25-hydroxy
D3; ECM: Extracellular matrix; OA: Osteoarthritis; OPG/
RANKL: Osteoprotegerin/receptor activator of nuclear factor kappa-B ligand;
RA: Rheumatoid arthritis; VDR: Vitamin D receptor
Acknowledgements
Thanks to Gunnar Knutsen and Geir Tore Abrahamsen, who provided the
cartilage biopsies, and to Kirsti Rønne and Ashraful Islam for technical
assistance.
Funding
The study was supported by the Northern Norway Regional Health
Authority. The publication charges for this article have been funded by a
grant from the publication fund of UiT The Arctic University of Norway.
Availability of data and materials
The datasets used and analysed during the current study are available from
the corresponding author on reasonable request.
Authors’ contributions
The experiments were performed by AKH and IZM, The manuscript was
drafted by AKH and revised by IZM and YF. All authors read and approved
the final manuscript.
Ethics approval and consent to participate
The study is approved by REK Nord (ref.nr. 2015/1730), and written consent




The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Orthopaedic Surgery, University Hospital of North Norway,
Tromsø, Norway. 2Bone and joint research group, Institute of Clinical
Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway.
3Department of Laboratory Medicine, University Hospital of North Norway,
Tromsø, Norway. 4Endocrinology Research Group, Institute of Clinical
Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway.
5Department of Medical Biology, Faculty of Health Sciences, University of
Tromsø, Tromsø, Norway.
Received: 9 April 2017 Accepted: 30 October 2017
References
1. Chaganti RK, Lane NE. Risk factors for incident osteoarthritis of the hip and
knee. Curr Rev Musculoskelet Med. 2011;4:99–104. 10.1007/s12178-011-9088-5.
2. Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in
osteoarthritis: a critical review of the state-of-the-art, current prospects, and
future challenges. Bone. 2016;85:81–90. 10.1016/j.bone.2016.01.019.
3. Mabey T, Honsawek S. Role of vitamin D in osteoarthritis: molecular,
cellular, and clinical perspectives. Int J Endocrinol. 2015;2015:383918. 10.
1155/2015/383918.
4. Mawer EB, Hayes ME, Still PE, Davies M, Lumb GA, Palit J, et al. Evidence for
nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with
inflammatory arthritis. J Bone Min Res. 1991;6:733–9. 10.1002/jbmr.
5650060711.
5. Morris HA, Anderson PH. Autocrine and paracrine actions of vitamin d. Clin
Biochem Rev. 2010;31:129–38. http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21170259
6. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem
Biophys. 2012;523:123–33. 10.1016/j.abb.2012.04.001.
7. Zhang FF, Driban JB, Lo GH, Price LL, Booth S, Eaton CB, et al. Vitamin D
deficiency is associated with progression of knee osteoarthritis. J Nutr. 2014;
144:2002–8. 10.3945/jn.114.193227.
8. Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, et al. Effect of vitamin D
supplementation on Tibial cartilage volume and knee pain among patients
with symptomatic knee osteoarthritis: a randomized clinical trial. JAMA.
2016;315:1005–13. 10.1001/jama.2016.1961.
9. Tetlow LC, Woolley DE. The effects of 1 alpha,25-dihydroxyvitamin D(3) on
matrix metalloproteinase and prostaglandin E(2) production by cells of the
rheumatoid lesion. Arthritis Res. 1999;1:63–70. 10.1186/ar12.
10. Bhalla AK, Wojno WC, Goldring MB. Human articular chondrocytes
acquire 1,25-(OH)2 vitamin D-3 receptors in culture. Biochim Biophys
Acta. 1987;931:26–32.
11. Tetlow LC, Woolley DE. Expression of vitamin D receptors and matrix
metalloproteinases in osteoarthritic cartilage and human articular
chondrocytes in vitro. Osteoarthr Cartil. 2001;9:423–31. 10.1053/joca.
2000.0408.
12. Chen D, Li Y, Dai X, Zhou X, Tian W, Zhou Y, et al. 1,25-Dihydroxyvitamin D3
activates MMP13 gene expression in chondrocytes through p38 MARK
pathway. Int J Biol Sci. 2013;9:649–55. 10.7150/ijbs.6726.
13. Orfanidou T, Malizos KN, Varitimidis S, Tsezou A. 1,25-
Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate
mitogen-activated protein kinase pathway through fibroblast growth
factor 23 contributing to hypertrophy and mineralization in
osteoarthritic chondrocytes. Exp Biol Med. 2012;237:241–53. 10.1258/
ebm.2011.011301.
14. Martinez I, Elvenes J, Olsen R, Bertheussen K, Johansen O. Redifferentiation
of in vitro expanded adult articular chondrocytes by combining the
hanging-drop cultivation method with hypoxic environment. Cell Transpl.
2008;17:987–96. http://www.ncbi.nlm.nih.gov/pubmed/19069640
15. Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and
versatile vitamin D receptor antibody. Arch Biochem Biophys. 2010;494:166–
77. 10.1016/j.abb.2009.11.029.
16. A Islam, AK Hansen, C Mennan, I Martinez-Zubiaurre. Mesenchymal stromal
cells from human umbilical cords display poor chondrogenic potential in
scaffold-free three dimensional cultures. European Cells and Materials. 2016;
31:407-424
17. Grogan SP, Barbero A, Winkelmann V, Rieser F, Fitzsimmons JS, O’Driscoll S, et al.
Visual histological grading system for the evaluation of in vitro-generated
neocartilage. Tissue Eng. 2006;12:2141–9. 10.1089/ten.2006.12.2141.
18. Witzel F, Fritsche-Guenther R, Lehmann N, Sieber A, Blüthgen N. Analysis of
impedance-based cellular growth assays. Bioinformatics. 2015;31:2705–12.
10.1093/bioinformatics/btv216.
19. Tokuyasu KT. Application of cryoultramicrotomy to
immunocytochemistry. J Microsc. 1986;143(Pt 2):139–49.
http://www.ncbi.nlm.nih.gov/pubmed/3531524
20. RStudio Team. RStudio: integrated development for R. 2016.
http://www.rstudio.com/.
21. Wickham H. tidyr: Easily Tidy Data with ‘spread()’ and ‘gather()’ Functions.
2016. https://cran.r-project.org/package=tidyr.
22. Wickham H, Francois R. Dplyr: a grammar of data manipulation. 2016.
https://cran.r-project.org/package=dplyr.
23. Robinson D. broom: Convert Statistical Analysis Objects into Tidy Data
Frames. 2017. https://cran.r-project.org/package=broom.
24. Dowle M, Srinivasan A. data.table: Extension of ‘data.frame’. 2017.
https://cran.r-project.org/package=data.table.
25. Wickham H. purrr: Functional Programming Tools. 2016.
https://cran.r-project.org/package=purrr.
26. Wickham H. ggplot2: Elegant Graphics for Data Analysis. 2009. http://ggplot2.org.
Hansen et al. BMC Musculoskeletal Disorders  (2017) 18:432 Page 12 of 13
27. Arnold JB. ggthemes: Extra Themes, Scales and Geoms for “ggplot2.” 2017.
https://cran.r-project.org/package=ggthemes.
28. Wickham H. The split-apply-combine strategy for data analysis. J Stat Softw.
2011;40:1–29.
29. Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic
diseases. Arthritis Res Ther. 2009;11:224. 10.1186/ar2592.
30. Feng X, Lv C, Wang F, Gan K, Zhang M, Tan W. Modulatory effect of 1,25-
dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α, and IL-6
expression in human rheumatoid synoviocyte MH7A. Clin Dev Immunol.
2013;2013:160123. 10.1155/2013/160123.
31. Tetlow LC, Smith SJ, Mawer EB, Woolley DE. Vitamin D receptors in the
rheumatoid lesion: expression by chondrocytes, macrophages, and
synoviocytes. Ann Rheum Dis. 1999;58:118–21. http://ard.bmj.com/content/
58/2/118.full.pdf
32. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the
regulation of gene expression by 1,25-Dihydroxyvitamin D3. Endocrinol
Metab. 2010;39:255–69.
33. van der Meijden K, Lips P, van Driel M, Heijboer AC, Schulten EAJM,
den HM, et al. Primary human Osteoblasts in response to 25-
Hydroxyvitamin D3, 1,25-Dihydroxyvitamin D3 and 24R,25-
Dihydroxyvitamin D3. PLoS One. 2014;9:e110283. 10.1371/journal.pone.
0110283.
34. van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, et al.
Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase
expression and activity in human bone cells. FASEB J. 2006;20:2417–9.
35. Goltzman D, Hendy GN, White JH. Vitamin D and its receptor during late
development. Biochim Biophys Acta - Gene Regul Mech. 2015;1849:171–80.
10.1016/j.bbagrm.2014.05.026.
36. Weber L, Hügel U, Reichrath J, Sieverts H, Mehls O, Klaus G. Cultured rat
growth plate chondrocytes express low levels of 1alpha-hydroxylase. Recent
Results Cancer Res. 2003;164:147–9. http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12899519
37. Smith SJ, Hayes ME, Selby PL, Mawer EB. Autocrine control of vitamin D
metabolism in synovial cells from arthritic patients. Ann Rheum Dis. 1999;58:372–
8. http://www.ncbi.nlm.nih.gov/pubmed/10340962. Accessed 20 Jan 2017
38. Hayes ME, Denton J, Freemont AJ, Mawer EB. Synthesis of the active
metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in
arthritic diseases. Ann Rheum Dis. 1989;48:723–9. http://www.ncbi.nlm.nih.
gov/pubmed/2802793
39. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213:626–34. 10.
1002/jcp.21258.
40. Norman AW. Vitamin D receptor: new assignments for an already busy
receptor. Endocrinology. 2006;147:5542–8. 10.1210/en.2006-0946.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Hansen et al. BMC Musculoskeletal Disorders  (2017) 18:432 Page 13 of 13
